Seki Kyosuke, Yoneda Keisuke, Yoneda Yu, Takenaka Yuki, Kaburaki Toshikatu, Takeuchi Masaru
Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
Department of Ophthalmology, Jichi Medical University Saitama Medical Center, Ohmiya, Japan.
Ocul Immunol Inflamm. 2025 May;33(4):662-669. doi: 10.1080/09273948.2024.2435477. Epub 2024 Dec 5.
This study aimed to investigate the clinical characteristics, diagnostic markers, and treatment outcomes of varicella-zoster virus-associated anterior uveitis (VZV-AU) with and without ophthalmic herpes zoster (herpes zoster ophthalmicus (HZO) and zoster sine herpete (ZSH), respectively).
Clinical records of 47 VZV-AU patients (21 ZSH, 26 hZO) were retrospectively reviewed for clinical findings, medication use, and PCR using aqueous humor (AH) results.
There was no significant difference in age, gender, visual acuity (VA), or intraocular pressure (IOP) between the two groups. At the initial visit, small-to-medium white keratic precipitates (KPs) were significantly more observed in ZSH group than in HZO group, although there was no significant difference in the frequencies of other ocular findings between the two groups. Early antiviral medication use was significantly higher in HZO group (96.2%) than in ZSH group (19.1%). PCR was performed in 85.7% of ZSH and 53.8% of HZO patients. VZV-DNA positivity and viral load were similar between groups. Multivariate analysis revealed a positive correlation between white KPs and VZV viral load in AH. Although the ultimate use of antiviral medication was still less in ZSH group (71.4%), there were no significant differences in VA and IOP at the last visit between the two groups.
Patients with ZSH had more white KPs and received less early antiviral medication than those with HZO. However, visual outcomes were similar between the two groups. Small-to-medium white KPs were significantly associated with the viral load of VZV in AH, suggesting that they could be an active marker.
本研究旨在调查伴或不伴眼部带状疱疹(分别为眼带状疱疹(HZO)和无疹性带状疱疹(ZSH))的水痘-带状疱疹病毒相关性前葡萄膜炎(VZV-AU)的临床特征、诊断标志物及治疗结果。
回顾性分析47例VZV-AU患者(21例ZSH,26例HZO)的临床记录,包括临床发现、用药情况及房水(AH)的聚合酶链反应(PCR)结果。
两组患者在年龄、性别、视力(VA)或眼压(IOP)方面无显著差异。初诊时,ZSH组比HZO组更易观察到中小白色角膜后沉着物(KPs),尽管两组其他眼部表现的发生率无显著差异。HZO组早期抗病毒药物使用率(96.2%)显著高于ZSH组(19.1%)。85.7%的ZSH患者和53.8%的HZO患者进行了PCR检测。两组间VZV-DNA阳性率和病毒载量相似。多因素分析显示白色KPs与AH中VZV病毒载量呈正相关。尽管ZSH组最终抗病毒药物使用率仍较低(71.4%),但两组末次随访时的VA和IOP无显著差异。
与HZO患者相比,ZSH患者有更多白色KPs且早期抗病毒药物使用较少。然而,两组的视觉预后相似。中小白色KPs与AH中VZV病毒载量显著相关,提示它们可能是一个活跃标志物。